Scotiabank says its 3 biotech ‘top pick’ stocks have more than 100% upside potential

The bank says it believes interest rate cuts are a “notable tailwind that will likely reignite wider investment interest” in the biotech sector.

Leave a Reply

Your email address will not be published. Required fields are marked *